An atypical caspase-independent death pathway for an immunogenic cancer cell line

REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell mono...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2002-09, Vol.21 (39), p.6091-6100
Hauptverfasser: LARMONIER, Nicolas, BILLEREY, Claire, BONNOTTE, Bernard, REBE, Cédric, PARCELLIER, Arnaud, MOUTET, Monique, FROMENTIN, Annie, KROEMER, Guido, GARRIDO, Carmen, SOLARY, Eric, MARTIN, Francois
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6100
container_issue 39
container_start_page 6091
container_title Oncogene
container_volume 21
creator LARMONIER, Nicolas
BILLEREY, Claire
BONNOTTE, Bernard
REBE, Cédric
PARCELLIER, Arnaud
MOUTET, Monique
FROMENTIN, Annie
KROEMER, Guido
GARRIDO, Carmen
SOLARY, Eric
MARTIN, Francois
description REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell monolayers release dead cells, especially when cultured in serum-free medium. In the current study, we show that the release of dead cells results from an atypical death process associating features of necrosis and apoptosis. In spite of features considered as hallmarks of caspase-dependent apoptosis, including chromatin fragmentation and DNA oligonucleosomal cleavage, caspases are not activated and caspase inhibitors are ineffective to prevent REGb cell death. In contrast with a number of other types of cell death, the spontaneous death of REGb cells in culture depends on de novo protein synthesis as this death is blocked by low doses of the mRNA translation inhibitor cycloheximide. This unusual mode of cell death that associates necrotic and apoptotic features could provide optimal conditions for triggering a specific immune response.
doi_str_mv 10.1038/sj.onc.1205738
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72038648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A205597055</galeid><sourcerecordid>A205597055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-636c9487008b43991255ad8a1d430228b7d16dd168840f4041d83a63e1ab21fd3</originalsourceid><addsrcrecordid>eNqFksuLFDEQxoO4uOPq1aM0it56zPtxHBYfCwvLgp5DJkmvGbrTbdLNMv-9NdgwICsSUoHwq6-qqA-hNwRvCWb6Uz1sx-y3hGKhmH6GNoQr2Qph-HO0wUbg1lBGL9HLWg8YY2UwfYEuCaWYEUo26H6XGzcfp-Rd33hXJ1djm3KIU4SQ5yZEN_9sJgiP7th0Y2lcbtIwLHl8iDl5SMo-lsbHvm_6lOMrdNG5vsbX63uFfnz5_P36W3t79_Xmenfbeq743EomveFaYaz3nBlDqBAuaEcCZ5hSvVeByABXa447jjkJmjnJInF7SrrArtDHP7pTGX8tsc52SPXUhctxXKpVMKKWXP8XJFpgTagC8P1f4GFcSoYhLJWcMKqkJEC9-ycFIkAac5Z6cH20KXfjXJw_1bU7WJUwCgJQ2ycoOCEOyY85dgn-n0rwZay1xM5OJQ2uHC3B9uQHWw8W_GBXP0DC27XZZT_EcMZXAwDwYQVcBQt0BbaZ6pljBksmKPsN5ee5oQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227326499</pqid></control><display><type>article</type><title>An atypical caspase-independent death pathway for an immunogenic cancer cell line</title><source>MEDLINE</source><source>Nature Journals Online</source><source>EZB-FREE-00999 freely available EZB journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>LARMONIER, Nicolas ; BILLEREY, Claire ; BONNOTTE, Bernard ; REBE, Cédric ; PARCELLIER, Arnaud ; MOUTET, Monique ; FROMENTIN, Annie ; KROEMER, Guido ; GARRIDO, Carmen ; SOLARY, Eric ; MARTIN, Francois</creator><creatorcontrib>LARMONIER, Nicolas ; BILLEREY, Claire ; BONNOTTE, Bernard ; REBE, Cédric ; PARCELLIER, Arnaud ; MOUTET, Monique ; FROMENTIN, Annie ; KROEMER, Guido ; GARRIDO, Carmen ; SOLARY, Eric ; MARTIN, Francois</creatorcontrib><description>REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell monolayers release dead cells, especially when cultured in serum-free medium. In the current study, we show that the release of dead cells results from an atypical death process associating features of necrosis and apoptosis. In spite of features considered as hallmarks of caspase-dependent apoptosis, including chromatin fragmentation and DNA oligonucleosomal cleavage, caspases are not activated and caspase inhibitors are ineffective to prevent REGb cell death. In contrast with a number of other types of cell death, the spontaneous death of REGb cells in culture depends on de novo protein synthesis as this death is blocked by low doses of the mRNA translation inhibitor cycloheximide. This unusual mode of cell death that associates necrotic and apoptotic features could provide optimal conditions for triggering a specific immune response.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/sj.onc.1205738</identifier><identifier>PMID: 12203121</identifier><identifier>CODEN: ONCNES</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing</publisher><subject>Ageing, cell death ; Amino Acid Chloromethyl Ketones - pharmacology ; Animals ; Annexin A5 - metabolism ; Apoptosis ; Apoptosis - physiology ; Apoptosis Inducing Factor ; Biological and medical sciences ; Cancer ; Caspase ; Caspase Inhibitors ; Caspases - metabolism ; Cell culture ; Cell death ; Cell physiology ; Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes ; Chromatin ; Chromatin - metabolism ; Colon cancer ; Cycloheximide ; Cycloheximide - pharmacology ; Cysteine Proteinase Inhibitors - pharmacology ; Dendritic cells ; Deoxyribonucleases - metabolism ; DNA ; DNA fragmentation ; Fas Ligand Protein ; Flavoproteins - metabolism ; Fundamental and applied biological sciences. Psychology ; Immune response ; Immunoblotting ; Immunogenicity ; Ligands ; Membrane Glycoproteins - metabolism ; Membrane Potentials - physiology ; Membrane Proteins - metabolism ; Mitochondria - metabolism ; Molecular and cellular biology ; Monomolecular films ; mRNA ; Necrosis ; Nucleosomes - metabolism ; Plasma ; Protein biosynthesis ; Protein synthesis ; Protein Synthesis Inhibitors - pharmacology ; Proteins ; Rats ; RNA ; Serum-free medium ; Tumor Cells, Cultured - drug effects ; Tumor Cells, Cultured - immunology ; Tumor Cells, Cultured - pathology ; Tumors</subject><ispartof>Oncogene, 2002-09, Vol.21 (39), p.6091-6100</ispartof><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2002 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Sep 5, 2002</rights><rights>Macmillan Publishers Limited 2002.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-636c9487008b43991255ad8a1d430228b7d16dd168840f4041d83a63e1ab21fd3</citedby><cites>FETCH-LOGICAL-c474t-636c9487008b43991255ad8a1d430228b7d16dd168840f4041d83a63e1ab21fd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13906352$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12203121$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LARMONIER, Nicolas</creatorcontrib><creatorcontrib>BILLEREY, Claire</creatorcontrib><creatorcontrib>BONNOTTE, Bernard</creatorcontrib><creatorcontrib>REBE, Cédric</creatorcontrib><creatorcontrib>PARCELLIER, Arnaud</creatorcontrib><creatorcontrib>MOUTET, Monique</creatorcontrib><creatorcontrib>FROMENTIN, Annie</creatorcontrib><creatorcontrib>KROEMER, Guido</creatorcontrib><creatorcontrib>GARRIDO, Carmen</creatorcontrib><creatorcontrib>SOLARY, Eric</creatorcontrib><creatorcontrib>MARTIN, Francois</creatorcontrib><title>An atypical caspase-independent death pathway for an immunogenic cancer cell line</title><title>Oncogene</title><addtitle>Oncogene</addtitle><description>REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell monolayers release dead cells, especially when cultured in serum-free medium. In the current study, we show that the release of dead cells results from an atypical death process associating features of necrosis and apoptosis. In spite of features considered as hallmarks of caspase-dependent apoptosis, including chromatin fragmentation and DNA oligonucleosomal cleavage, caspases are not activated and caspase inhibitors are ineffective to prevent REGb cell death. In contrast with a number of other types of cell death, the spontaneous death of REGb cells in culture depends on de novo protein synthesis as this death is blocked by low doses of the mRNA translation inhibitor cycloheximide. This unusual mode of cell death that associates necrotic and apoptotic features could provide optimal conditions for triggering a specific immune response.</description><subject>Ageing, cell death</subject><subject>Amino Acid Chloromethyl Ketones - pharmacology</subject><subject>Animals</subject><subject>Annexin A5 - metabolism</subject><subject>Apoptosis</subject><subject>Apoptosis - physiology</subject><subject>Apoptosis Inducing Factor</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Caspase</subject><subject>Caspase Inhibitors</subject><subject>Caspases - metabolism</subject><subject>Cell culture</subject><subject>Cell death</subject><subject>Cell physiology</subject><subject>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</subject><subject>Chromatin</subject><subject>Chromatin - metabolism</subject><subject>Colon cancer</subject><subject>Cycloheximide</subject><subject>Cycloheximide - pharmacology</subject><subject>Cysteine Proteinase Inhibitors - pharmacology</subject><subject>Dendritic cells</subject><subject>Deoxyribonucleases - metabolism</subject><subject>DNA</subject><subject>DNA fragmentation</subject><subject>Fas Ligand Protein</subject><subject>Flavoproteins - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Immune response</subject><subject>Immunoblotting</subject><subject>Immunogenicity</subject><subject>Ligands</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Membrane Potentials - physiology</subject><subject>Membrane Proteins - metabolism</subject><subject>Mitochondria - metabolism</subject><subject>Molecular and cellular biology</subject><subject>Monomolecular films</subject><subject>mRNA</subject><subject>Necrosis</subject><subject>Nucleosomes - metabolism</subject><subject>Plasma</subject><subject>Protein biosynthesis</subject><subject>Protein synthesis</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>Proteins</subject><subject>Rats</subject><subject>RNA</subject><subject>Serum-free medium</subject><subject>Tumor Cells, Cultured - drug effects</subject><subject>Tumor Cells, Cultured - immunology</subject><subject>Tumor Cells, Cultured - pathology</subject><subject>Tumors</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFksuLFDEQxoO4uOPq1aM0it56zPtxHBYfCwvLgp5DJkmvGbrTbdLNMv-9NdgwICsSUoHwq6-qqA-hNwRvCWb6Uz1sx-y3hGKhmH6GNoQr2Qph-HO0wUbg1lBGL9HLWg8YY2UwfYEuCaWYEUo26H6XGzcfp-Rd33hXJ1djm3KIU4SQ5yZEN_9sJgiP7th0Y2lcbtIwLHl8iDl5SMo-lsbHvm_6lOMrdNG5vsbX63uFfnz5_P36W3t79_Xmenfbeq743EomveFaYaz3nBlDqBAuaEcCZ5hSvVeByABXa447jjkJmjnJInF7SrrArtDHP7pTGX8tsc52SPXUhctxXKpVMKKWXP8XJFpgTagC8P1f4GFcSoYhLJWcMKqkJEC9-ycFIkAac5Z6cH20KXfjXJw_1bU7WJUwCgJQ2ycoOCEOyY85dgn-n0rwZay1xM5OJQ2uHC3B9uQHWw8W_GBXP0DC27XZZT_EcMZXAwDwYQVcBQt0BbaZ6pljBksmKPsN5ee5oQ</recordid><startdate>20020905</startdate><enddate>20020905</enddate><creator>LARMONIER, Nicolas</creator><creator>BILLEREY, Claire</creator><creator>BONNOTTE, Bernard</creator><creator>REBE, Cédric</creator><creator>PARCELLIER, Arnaud</creator><creator>MOUTET, Monique</creator><creator>FROMENTIN, Annie</creator><creator>KROEMER, Guido</creator><creator>GARRIDO, Carmen</creator><creator>SOLARY, Eric</creator><creator>MARTIN, Francois</creator><general>Nature Publishing</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20020905</creationdate><title>An atypical caspase-independent death pathway for an immunogenic cancer cell line</title><author>LARMONIER, Nicolas ; BILLEREY, Claire ; BONNOTTE, Bernard ; REBE, Cédric ; PARCELLIER, Arnaud ; MOUTET, Monique ; FROMENTIN, Annie ; KROEMER, Guido ; GARRIDO, Carmen ; SOLARY, Eric ; MARTIN, Francois</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-636c9487008b43991255ad8a1d430228b7d16dd168840f4041d83a63e1ab21fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Ageing, cell death</topic><topic>Amino Acid Chloromethyl Ketones - pharmacology</topic><topic>Animals</topic><topic>Annexin A5 - metabolism</topic><topic>Apoptosis</topic><topic>Apoptosis - physiology</topic><topic>Apoptosis Inducing Factor</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Caspase</topic><topic>Caspase Inhibitors</topic><topic>Caspases - metabolism</topic><topic>Cell culture</topic><topic>Cell death</topic><topic>Cell physiology</topic><topic>Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes</topic><topic>Chromatin</topic><topic>Chromatin - metabolism</topic><topic>Colon cancer</topic><topic>Cycloheximide</topic><topic>Cycloheximide - pharmacology</topic><topic>Cysteine Proteinase Inhibitors - pharmacology</topic><topic>Dendritic cells</topic><topic>Deoxyribonucleases - metabolism</topic><topic>DNA</topic><topic>DNA fragmentation</topic><topic>Fas Ligand Protein</topic><topic>Flavoproteins - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Immune response</topic><topic>Immunoblotting</topic><topic>Immunogenicity</topic><topic>Ligands</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Membrane Potentials - physiology</topic><topic>Membrane Proteins - metabolism</topic><topic>Mitochondria - metabolism</topic><topic>Molecular and cellular biology</topic><topic>Monomolecular films</topic><topic>mRNA</topic><topic>Necrosis</topic><topic>Nucleosomes - metabolism</topic><topic>Plasma</topic><topic>Protein biosynthesis</topic><topic>Protein synthesis</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>Proteins</topic><topic>Rats</topic><topic>RNA</topic><topic>Serum-free medium</topic><topic>Tumor Cells, Cultured - drug effects</topic><topic>Tumor Cells, Cultured - immunology</topic><topic>Tumor Cells, Cultured - pathology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LARMONIER, Nicolas</creatorcontrib><creatorcontrib>BILLEREY, Claire</creatorcontrib><creatorcontrib>BONNOTTE, Bernard</creatorcontrib><creatorcontrib>REBE, Cédric</creatorcontrib><creatorcontrib>PARCELLIER, Arnaud</creatorcontrib><creatorcontrib>MOUTET, Monique</creatorcontrib><creatorcontrib>FROMENTIN, Annie</creatorcontrib><creatorcontrib>KROEMER, Guido</creatorcontrib><creatorcontrib>GARRIDO, Carmen</creatorcontrib><creatorcontrib>SOLARY, Eric</creatorcontrib><creatorcontrib>MARTIN, Francois</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LARMONIER, Nicolas</au><au>BILLEREY, Claire</au><au>BONNOTTE, Bernard</au><au>REBE, Cédric</au><au>PARCELLIER, Arnaud</au><au>MOUTET, Monique</au><au>FROMENTIN, Annie</au><au>KROEMER, Guido</au><au>GARRIDO, Carmen</au><au>SOLARY, Eric</au><au>MARTIN, Francois</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An atypical caspase-independent death pathway for an immunogenic cancer cell line</atitle><jtitle>Oncogene</jtitle><addtitle>Oncogene</addtitle><date>2002-09-05</date><risdate>2002</risdate><volume>21</volume><issue>39</issue><spage>6091</spage><epage>6100</epage><pages>6091-6100</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><coden>ONCNES</coden><abstract>REGb cell line, a highly immunogenic tumor cell variant isolated from a rat colon cancer, yields regressive tumors when injected into syngeneic hosts. We previously demonstrated that REGb tumor immunogenicity was related to the capacity of releasing dead cells in vivo. Also, in vitro, REGb cell monolayers release dead cells, especially when cultured in serum-free medium. In the current study, we show that the release of dead cells results from an atypical death process associating features of necrosis and apoptosis. In spite of features considered as hallmarks of caspase-dependent apoptosis, including chromatin fragmentation and DNA oligonucleosomal cleavage, caspases are not activated and caspase inhibitors are ineffective to prevent REGb cell death. In contrast with a number of other types of cell death, the spontaneous death of REGb cells in culture depends on de novo protein synthesis as this death is blocked by low doses of the mRNA translation inhibitor cycloheximide. This unusual mode of cell death that associates necrotic and apoptotic features could provide optimal conditions for triggering a specific immune response.</abstract><cop>Basingstoke</cop><pub>Nature Publishing</pub><pmid>12203121</pmid><doi>10.1038/sj.onc.1205738</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2002-09, Vol.21 (39), p.6091-6100
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_miscellaneous_72038648
source MEDLINE; Nature Journals Online; EZB-FREE-00999 freely available EZB journals; SpringerLink Journals - AutoHoldings
subjects Ageing, cell death
Amino Acid Chloromethyl Ketones - pharmacology
Animals
Annexin A5 - metabolism
Apoptosis
Apoptosis - physiology
Apoptosis Inducing Factor
Biological and medical sciences
Cancer
Caspase
Caspase Inhibitors
Caspases - metabolism
Cell culture
Cell death
Cell physiology
Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
Chromatin
Chromatin - metabolism
Colon cancer
Cycloheximide
Cycloheximide - pharmacology
Cysteine Proteinase Inhibitors - pharmacology
Dendritic cells
Deoxyribonucleases - metabolism
DNA
DNA fragmentation
Fas Ligand Protein
Flavoproteins - metabolism
Fundamental and applied biological sciences. Psychology
Immune response
Immunoblotting
Immunogenicity
Ligands
Membrane Glycoproteins - metabolism
Membrane Potentials - physiology
Membrane Proteins - metabolism
Mitochondria - metabolism
Molecular and cellular biology
Monomolecular films
mRNA
Necrosis
Nucleosomes - metabolism
Plasma
Protein biosynthesis
Protein synthesis
Protein Synthesis Inhibitors - pharmacology
Proteins
Rats
RNA
Serum-free medium
Tumor Cells, Cultured - drug effects
Tumor Cells, Cultured - immunology
Tumor Cells, Cultured - pathology
Tumors
title An atypical caspase-independent death pathway for an immunogenic cancer cell line
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A27%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20atypical%20caspase-independent%20death%20pathway%20for%20an%20immunogenic%20cancer%20cell%20line&rft.jtitle=Oncogene&rft.au=LARMONIER,%20Nicolas&rft.date=2002-09-05&rft.volume=21&rft.issue=39&rft.spage=6091&rft.epage=6100&rft.pages=6091-6100&rft.issn=0950-9232&rft.eissn=1476-5594&rft.coden=ONCNES&rft_id=info:doi/10.1038/sj.onc.1205738&rft_dat=%3Cgale_proqu%3EA205597055%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227326499&rft_id=info:pmid/12203121&rft_galeid=A205597055&rfr_iscdi=true